title: [Immunotherapy of squamous cell carcinoma of the bovine eye and of equine sarcoid].
abstract: Squamous cell carcinomas of the bovine eye and equine sarcoids are briefly reviewed. A single injection of BCG into the tumour results in permanent regression of the lesion in 37 per cent of the cattle, regression followed by recurrence of the tumour in 26 per cent and in progressive growth of the tumour in 37 per cent of the cases. Recurrence may be prevented by repeated injection into the lesion. From 50 to 60 per cent of the cows will remain free from tumours. Equine sarcoids show a complete regression in 70-80 per cent of the cases. Tumours on the limbs show a less satisfactory response (lower rates of success, more complications) than do tumours in other areas of the body.
authors: Vakgroep Algemene Heelkunde, Utrecht.
authors: W R
authors: WR
authors: Klein
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000628:therapy / Q000662:veterinary*; D002417:Cattle; D002418:Cattle Diseases / Q000628:therapy*; D005134:Eye Neoplasms / Q000628:therapy / Q000662:veterinary*; D006734:Horse Diseases / Q000628:therapy*; D006736:Horses; D012507:Sarcoidosis / Q000628:therapy / Q000662:veterinary*
chemical_list: D001500:BCG Vaccine
vernacular_title: Immunotherapie van het plaveiselcelcarcinoom bij het runderoog en het sarcoïd bij het paard.